[Source](https://github.com/mm80843/T3.5/blob/main/docs/index.md) -- [Benef](https://github.com/mm80843/T3.5/tree/main/docs/Benef/index.md) 

# Benef: __Improved management of liver transplant recipients__ (PBN__Benef_361)

## Property: has_BenefDetails

Giving attention to liver transplant recipients with metabolic comorbidities and maintaining their immunosuppression can lead to better management and outcomes for these patients during the COVID-19 pandemic.

## Property: has_BenefSource

* [lodder_sars-cov-2_2020](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_70.md)

## Description of Benefits pertaining to Beneficiaries

* [Private investors can benefit by ensuring the availability of adequate healthcare facilities and services for liver transplant recipients, which enhances the reputation and demand for healthcare-related properties in the built environment.](https://github.com/mm80843/T3.5/blob/main/docs/BenefReturn/PBN__BenefReturn_388.md)

## Property: has_Beneficiary

* [liver transplant recipients with metabolic comorbidities](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_175.md)

